Shine-on Biomedical Co., Ltd.
Clinical trials sponsored by Shine-on Biomedical Co., Ltd., explained in plain language.
-
New Triple-Action drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called SOA101, a tri-specific antibody designed to help the immune system attack cancer cells. It is for people with advanced solid tumors (lung, ovarian, head and neck, breast, or colorectal cancer) who have no other treatment options. The trial will …
Phase: PHASE1, PHASE2 • Sponsor: Shine-On Biomedical Co., Ltd. • Aim: Disease control
Last updated May 01, 2026 16:04 UTC
-
First human test of exosome drug begins – no cure yet, just safety check
Knowledge-focused Recruiting nowThis early-stage study tests a new drug called SOB100 in 15 healthy volunteers to see if it is safe and how the body processes it. SOB100 is a tiny particle (exosome) designed to target a specific protein (HLA-G). The study does not aim to treat any disease; it only checks for si…
Phase: PHASE1 • Sponsor: Shine-On Biomedical Co., Ltd. • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC